AQR Capital Management’s PhenomeX Inc. Common Stock CELL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-492,751
Closed -$241K 2412
2023
Q2
$241K Sell
492,751
-1,495,790
-75% -$1.22M ﹤0.01% 2020
2023
Q1
$2.31M Buy
1,988,541
+1,431,113
+257% +$2.62M 0.01% 1196
2022
Q4
$1.49M Buy
557,428
+290,154
+109% +$765K ﹤0.01% 1383
2022
Q3
$764K Buy
267,274
+244,050
+1,051% +$1.04M ﹤0.01% 1614
2022
Q2
$115K Sell
23,224
-87,510
-79% -$458K ﹤0.01% 2076
2022
Q1
$787K Buy
+110,734
New +$916K ﹤0.01% 1647

Other funds holding CELL

AQR Capital Management's CELL Position: Q3 2023 in Review

AQR Capital Management sold out of PhenomeX Inc. Common Stock (CELL) in Q3 2023, closing a stake of 492,751 shares — an estimated $241K sold.

AQR Capital Management first reported a position in CELL in Q1 2022 and held it in 6 quarters. The position peaked at $2.31M in Q1 2023. 57 funds tracked by Wall St. Rank hold CELL as of Q3 2023.

  • AQR Capital Management reported no remaining PhenomeX Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • AQR Capital Management sold 492,751 PhenomeX Inc. Common Stock shares in Q3 2023, an estimated $241K.
  • AQR Capital Management first reported a position in PhenomeX Inc. Common Stock in Q1 2022 and held it in 6 quarters.
  • AQR Capital Management's PhenomeX Inc. Common Stock position peaked at $2.31M in Q1 2023.
  • 57 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q3 2023.

Based on AQR Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.